Simtra is a leading pharmaceutical contract development and manufacturing organization (“CDMO”) spun out of Baxter (Baxter International Inc.), a leading global medtech company. Simtra is a provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services, with facilities in Bloomington, IN and Halle, Germany.
Location: United States
Investors 2
| Date | Name | Website |
| 11.11.2023 | Warburg Pi... | warburgpin... |
| - | Advent Int... | adventinte... |
Mentions in press and media 3
| Date | Title | Description |
| 07.10.2024 | Simtra BioPharma Solutions Expands Capabilities with $14M Investment in ADC Conjugation and Purification Clinical Suite | PARSIPPANY, N.J., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, has announced a $14 million investment to expand its c... |
| 07.10.2024 | Simtra BioPharma Solutions Expands Capabilities with $14M Investment in ADC Conjugation and Purification Clinical Suite | Enhancing End-to-End Service Offering for Accelerated Development and Manufacturing of Antibody-Drug Conjugates (ADCs) as part of the scaling of its Development Services Business PARSIPPANY, N.J., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Simtra Bi... |
| 28.02.2024 | Simtra BioPharma Solutions Announces $250+ Million Investment to Expand Sterile Fill/Finish Manufacturing Site in Bloomington, Indiana | Simtra BioPharma Solutions announced a $250+ million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana. Expansion designed to meet customers' growing demand and need for development services, clinical and com... |